PBT-1033, formerly known as PBT-2, is a neural protective agent potentially for the treatment of Alzheimer's disease and Huntington's Disease. References: Huntington Study Group Reach2HD Investigators.. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015 Jan;14(1):39-47. doi: 10.1016/S1474-4422(14)70262-5. PubMed PMID: 25467848.

纯度：≥98%

CAS：648896-70-2